Skip to main content
Premium Trial:

Request an Annual Quote

Epoch Q2 Revenues Flat

NEW YORK, Aug. 5 (GenomeWeb News) - Epoch Biosciences reported flat revenues for the second quarter today, amid widened net losses.


The company's revenues totaled $2.5 million for both this quarter and the second quarter of 2002.


Net losses for the Bothell, Wash.-based company widened to $3.1 million, compared to $1.2 million for the year-ago quarter.


R&D expenses were also flat at $1.1 million, compared to $1.1 million for the second quarter of 2002.


As of June 30, Epoch had $4.6 million in cash and cash equivalents.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.